Thyroid cancer cell metabolism : A glance into cell culture system-based metabolomics approaches
Copyright © 2024 Elsevier Inc. All rights reserved..
Thyroid cancer is the most common malignancy of the endocrine system and the seventh most prevalent cancer in women worldwide. It is a complex and diverse disease characterized by heterogeneity, underscoring the importance of understanding the underlying metabolic alterations within tumor cells. Metabolomics technologies offer a powerful toolset to explore and identify endogenous and exogenous biochemical reaction products, providing crucial insights into the intricate metabolic pathways and processes within living cells. Metabolism plays a central role in cell function, making metabolomics a valuable reflection of a cell's phenotype. In the OMICs era, metabolomics analysis of cells brings numerous advantages over existing methods, propelling cell metabolomics as an emerging field with vast potential for investigating metabolic pathways and their perturbation in pathophysiological conditions. This review article aims to look into recent developments in applying metabolomics for characterizing and interpreting the cellular metabolome in thyroid cancer cell lines, exploring their unique metabolic characteristics. Understanding the metabolic alterations in tumor cells can lead to the identification of critical nodes in the metabolic network that could be targeted for therapeutic intervention.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:435 |
---|---|
Enthalten in: |
Experimental cell research - 435(2024), 2 vom: 15. Feb., Seite 113936 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Abooshahab, Raziyeh [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cell line models |
---|
Anmerkungen: |
Date Completed 16.02.2024 Date Revised 16.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.yexcr.2024.113936 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367686996 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367686996 | ||
003 | DE-627 | ||
005 | 20240216232749.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240127s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.yexcr.2024.113936 |2 doi | |
028 | 5 | 2 | |a pubmed24n1295.xml |
035 | |a (DE-627)NLM367686996 | ||
035 | |a (NLM)38278284 | ||
035 | |a (PII)S0014-4827(24)00026-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Abooshahab, Raziyeh |e verfasserin |4 aut | |
245 | 1 | 0 | |a Thyroid cancer cell metabolism |b A glance into cell culture system-based metabolomics approaches |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.02.2024 | ||
500 | |a Date Revised 16.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 Elsevier Inc. All rights reserved. | ||
520 | |a Thyroid cancer is the most common malignancy of the endocrine system and the seventh most prevalent cancer in women worldwide. It is a complex and diverse disease characterized by heterogeneity, underscoring the importance of understanding the underlying metabolic alterations within tumor cells. Metabolomics technologies offer a powerful toolset to explore and identify endogenous and exogenous biochemical reaction products, providing crucial insights into the intricate metabolic pathways and processes within living cells. Metabolism plays a central role in cell function, making metabolomics a valuable reflection of a cell's phenotype. In the OMICs era, metabolomics analysis of cells brings numerous advantages over existing methods, propelling cell metabolomics as an emerging field with vast potential for investigating metabolic pathways and their perturbation in pathophysiological conditions. This review article aims to look into recent developments in applying metabolomics for characterizing and interpreting the cellular metabolome in thyroid cancer cell lines, exploring their unique metabolic characteristics. Understanding the metabolic alterations in tumor cells can lead to the identification of critical nodes in the metabolic network that could be targeted for therapeutic intervention | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Cell line models | |
650 | 4 | |a Metabolic pathways | |
650 | 4 | |a Metabolism | |
650 | 4 | |a Metabolomics | |
650 | 4 | |a Thyroid cancer | |
700 | 1 | |a Razavi, Fatemeh |e verfasserin |4 aut | |
700 | 1 | |a Ghorbani, Fatemeh |e verfasserin |4 aut | |
700 | 1 | |a Hooshmand, Koroush |e verfasserin |4 aut | |
700 | 1 | |a Zarkesh, Maryam |e verfasserin |4 aut | |
700 | 1 | |a Hedayati, Mehdi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Experimental cell research |d 1953 |g 435(2024), 2 vom: 15. Feb., Seite 113936 |w (DE-627)NLM000003123 |x 1090-2422 |7 nnns |
773 | 1 | 8 | |g volume:435 |g year:2024 |g number:2 |g day:15 |g month:02 |g pages:113936 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.yexcr.2024.113936 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 435 |j 2024 |e 2 |b 15 |c 02 |h 113936 |